These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 16856115)

  • 1. Azapirones for generalized anxiety disorder.
    Chessick CA; Allen MH; Thase M; Batista Miralha da Cunha AB; Kapczinski FF; de Lima MS; dos Santos Souza JJ
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006115. PubMed ID: 16856115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azapirones versus placebo for panic disorder in adults.
    Imai H; Tajika A; Chen P; Pompoli A; Guaiana G; Castellazzi M; Bighelli I; Girlanda F; Barbui C; Koesters M; Cipriani A; Furukawa TA
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010828. PubMed ID: 25268297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyzine for generalised anxiety disorder.
    Guaiana G; Barbui C; Cipriani A
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006815. PubMed ID: 21154375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants for generalized anxiety disorder.
    Kapczinski F; Lima MS; Souza JS; Schmitt R
    Cochrane Database Syst Rev; 2003; (2):CD003592. PubMed ID: 12804478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for treating anxiety after stroke.
    Knapp P; Campbell Burton CA; Holmes J; Murray J; Gillespie D; Lightbody CE; Watkins CL; Chun HY; Lewis SR
    Cochrane Database Syst Rev; 2017 May; 5(5):CD008860. PubMed ID: 28535332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; 2001(2):CD003013. PubMed ID: 11406061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
    Casacalenda N; Boulenger JP
    Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiagabine in the maintenance treatment of bipolar disorders.
    Young AH; Geddes JR; Macritchie K; Rao SN; Vasudev A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005173. PubMed ID: 16856081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials.
    Rossano F; Caiazza C; Zotti N; Viacava L; Irano A; Solini N; Pistone L; Pezone R; Cilmi F; Ricci C; De Prisco M; Iasevoli F; Kishi T; Solmi M; de Bartolomeis A; Fornaro M
    Eur Neuropsychopharmacol; 2023 Nov; 76():23-51. PubMed ID: 37544075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of generalized anxiety disorder.
    Gorman JM
    J Clin Psychiatry; 2002; 63 Suppl 8():17-23. PubMed ID: 12044104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant plus benzodiazepine for major depression.
    Furukawa TA; Streiner DL; Young LT
    Cochrane Database Syst Rev; 2001; (2):CD001026. PubMed ID: 11405972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant and benzodiazepine for major depression.
    Furukawa TA; Streiner DL; Young LT
    Cochrane Database Syst Rev; 2002; (1):CD001026. PubMed ID: 11869584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.
    Ipser JC; Carey P; Dhansay Y; Fakier N; Seedat S; Stein DJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005473. PubMed ID: 17054260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate for depressive disorders.
    Taylor MJ; Carney S; Geddes J; Goodwin G
    Cochrane Database Syst Rev; 2003; 2003(2):CD003390. PubMed ID: 12804463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inositol for depressive disorders.
    Taylor MJ; Wilder H; Bhagwagar Z; Geddes J
    Cochrane Database Syst Rev; 2004; 2004(2):CD004049. PubMed ID: 15106232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for treating anxiety after stroke.
    Campbell Burton CA; Holmes J; Murray J; Gillespie D; Lightbody CE; Watkins CL; Knapp P
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008860. PubMed ID: 22161439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.